Commercial Services Healthcare Sector

Scancell Holdings

Market Cap: UK£100.2m

A clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease.

Prenetics Global

Market Cap: US$134.4m

A consumer health company, focuses on empowering individuals to take control of their health through science-backed solutions in Hong Kong, Taiwan, the United States, and internationally.

Global Cord Blood

Market Cap: US$133.9m

Provides umbilical cord blood storage and ancillary services in the People's Republic of China.

Fate Therapeutics

Market Cap: US$133.0m

A clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally.

Aldeyra Therapeutics

Market Cap: US$133.0m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

DocGo

Market Cap: US$132.8m

Provides mobile health and medical transportation services in the United States and the United Kingdom.

Oneview Healthcare

Market Cap: AU$205.4m

Develops and sells software services for the healthcare sector in Ireland, the United States, Australia, Ireland, the Middle East, and Asia.

Inhibikase Therapeutics

Market Cap: US$131.6m

Operates as a clinical-stage pharmaceutical company that develops therapeutics for Parkinson’s disease and related disorders.

Greenwich LifeSciences

Market Cap: US$131.1m

A clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers.

Vireo Growth

Market Cap: CA$180.0m

Operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, and New York.

Editas Medicine

Market Cap: US$129.8m

A clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases.

Korro Bio

Market Cap: US$129.6m

A biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States.

Protalix BioTherapeutics

Market Cap: US$129.0m

A biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system.

BioSig Technologies

Market Cap: US$128.1m

A medical technology company, provides digital signal processing technology platform services in the United States.

Seer

Market Cap: US$125.5m

A life sciences company, develops and commercializes products to decode the biology of the proteome.

InflaRx

Market Cap: US$125.3m

A clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology in Germany and the United States.

Pulmonx

Market Cap: US$125.2m

A commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease.

eXoZymes

Market Cap: US$124.7m

A development stage company focused on building a technology platform that can develop assets that can be reapplied multiple times in different markets with only small changes, while maintaining and capturing new fundamental IP in the application.

Enanta Pharmaceuticals

Market Cap: US$124.2m

A biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases.

Nkarta

Market Cap: US$124.2m

A clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment.

Alector

Market Cap: US$124.0m

A late-stage clinical biotechnology company, develops therapies that is focused on counteracting the devastating progression of neurodegenerative diseases.

TuHURA Biosciences

Market Cap: US$123.6m

A clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies.

Lyell Immunopharma

Market Cap: US$123.5m

A clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors.

Theratechnologies

Market Cap: CA$170.1m

A biopharmaceutical company, focuses on the commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe.

Jin Medical International

Market Cap: US$122.8m

Engages in the design, development, manufacture, and sale of wheelchair and other living aids products for people with disabilities, the elderly, and people recovering from injury.

KORU Medical Systems

Market Cap: US$122.7m

Develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally.

AOTI

Market Cap: UK£90.4m

Produces, rents, and sells medical devices to help resolve severe acute and chronic wounds for customers worldwide.

Nektar Therapeutics

Market Cap: US$121.7m

A biopharmaceutical company, focuses on discovering and developing therapies that selectively modulate the immune system to treat autoimmune disorders in the United States and internationally.

Protara Therapeutics

Market Cap: US$120.8m

A clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases.

Ventyx Biosciences

Market Cap: US$120.3m

A clinical-stage biopharmaceutical company, develops oral therapies for patients with autoimmune, inflammatory, and neurodegenerative diseases.

Larimar Therapeutics

Market Cap: US$119.7m

A clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform.

American Well

Market Cap: US$115.8m

An enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally.

HLS Therapeutics

Market Cap: CA$158.2m

A specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders, central nervous system, and cardiovascular disease in Canada, the United States, and internationally.

Black Diamond Therapeutics

Market Cap: US$114.3m

A clinical-stage oncology company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors.

InfuSystem Holdings

Market Cap: US$113.5m

Through its subsidiaries, provides infusion pumps and related products and services in the United States and Canada.

Sangamo Therapeutics

Market Cap: US$112.5m

A clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States.